Haemonetics (HAE) Tops Q1 EPS by 17c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.73 +0.30%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.59, $0.17 better than the analyst estimate of $0.42. Revenue for the quarter came in at $229.3 million versus the consensus estimate of $219.95 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.17.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Evercore lifts Ciena rating on AI-driven optical networking boom
- LEEF Brands appoints Hirsh Jain to board as independent director
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
